Clinical Trial Detail

NCT ID NCT02494167
Title Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

MultiTAA-specific T cells

Age Groups: adult senior child

No variant requirements are available.